Federal judge puts brakes on new 340B drug rebate program
Seeking Alpha News (Wed, 31-Dec 12:30 PM ET)
Community Health Systems, Inc. Announces Redemptions of Senior Secured Notes
Business Wire (Mon, 15-Dec 4:15 PM ET)
Business Wire (Wed, 10-Dec 4:15 PM ET)
Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp
Business Wire (Tue, 2-Dec 4:15 PM ET)
Community Health Systems Announces Participation in the 2025 UBS Global Healthcare Conference
Business Wire (Wed, 5-Nov 11:00 AM ET)
Business Wire (Thu, 30-Oct 4:30 PM ET)
Business Wire (Fri, 24-Oct 5:30 PM ET)
Market Chameleon (Fri, 24-Oct 7:08 AM ET)
Community Health Systems, Inc. Announces Third Quarter Ended September 30, 2025 Results
Business Wire (Thu, 23-Oct 4:15 PM ET)
Community Health Systems to Webcast Third Quarter 2025 Conference Call
Business Wire (Thu, 9-Oct 11:00 AM ET)
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
Community Health Systems trades on the NYSE stock market under the symbol CYH.
As of January 5, 2026, CYH stock price climbed to $3.26 with 939,241 million shares trading.
CYH has a beta of 1.84, meaning it tends to be more sensitive to market movements. CYH has a correlation of 0.21 to the broad based SPY ETF.
CYH has a market cap of $451.57 million. This is considered a Small Cap stock.
Last quarter Community Health Systems reported $3 billion in Revenue and $1.27 earnings per share. This beat revenue expectation by $99 million and exceeded earnings estimates by $1.57.
In the last 3 years, CYH traded as high as $8.01 and as low as $2.01.
The top ETF exchange traded funds that CYH belongs to (by Net Assets): VTI, IWM, VXF, FNDX, VTWO.
CYH has underperformed the market in the last year with a price return of +6.2% while the SPY ETF gained +18.9%. However, in the short term, CYH had mixed performance relative to the market. It has outperformed in the last 3 months, returning +8.3% vs +3.1% return in SPY. But in the last 2 weeks, CYH shares have been beat by the market, returning 0.0% compared to an SPY return of +1.0%.
CYH support price is $3.01 and resistance is $3.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CYH shares will trade within this expected range on the day.